ARTICLE | Company News
Aphios, VivaCell deal
June 17, 2013 7:00 AM UTC
The companies partnered to develop and commercialize non-psychotropic cannabinoid drug candidates to treat multiple sclerosis and other CNS neurodegenerative diseases in the U.S. and Europe. The compo...